2018
DOI: 10.7717/peerj.4297
|View full text |Cite
|
Sign up to set email alerts
|

Seroprevalence of hepatitis B virus in Taiwan 30 years after the commencement of the national vaccination program

Abstract: BackgroundIn this study, the long-term efficacy of hepatitis B virus (HBV) vaccination was assessed using seroprevalence and an age–period–cohort (APC) model of HBV seromarkers among university entrants 30 years after the introduction of the national neonatal HBV vaccination program in Taiwan.MethodsIn total, data of 17,611 university entrants who underwent university entrance health examinations between 2005 and 2016 were included. The seroprevalence of the HBV surface antigen (HBsAg) and the levels of the an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
43
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 51 publications
(45 citation statements)
references
References 31 publications
1
43
0
1
Order By: Relevance
“…The chronic HBV carrier rate among the general Taiwanese population ranged from 15% to 20% prior to the introduction of the national HBV vaccination program in 1984 [7]. The nationwide HBV vaccination campaign program has successfully reduced the prevalence rate of chronic HBV to <1.0% in people born after 1992 [8].…”
Section: Introductionmentioning
confidence: 99%
“…The chronic HBV carrier rate among the general Taiwanese population ranged from 15% to 20% prior to the introduction of the national HBV vaccination program in 1984 [7]. The nationwide HBV vaccination campaign program has successfully reduced the prevalence rate of chronic HBV to <1.0% in people born after 1992 [8].…”
Section: Introductionmentioning
confidence: 99%
“…Universal vaccination programs significantly decreased the HBV infection rate among all age groups born since the program was initiated. The effectiveness of the vaccination program has been demonstrated in various studies that have reported a decrease in the HBsAg carrier rate, incidence of chronic HBV infection, and rates of mother-to-child transmission [36][37][38] . A study assessing the long-term efficacy of HBV vaccination based on seroprevalence and an age-period-cohort model of HBV seromarkers in Taiwan showed that the HBsAg positivity rate among university students decreased from 9.7% among those born before June 1974 to <1.0% in those born after 1992 [38] .…”
Section: Discussionmentioning
confidence: 99%
“…U ovome se ogleda značaj vakcine ne samo u sprečavanju akutnih infekcija već i u prevenciji hroniciteta. Imunizacija protiv HBV infekcije, sprovedena na Tajvanu, pokazuje pad stope hronične infekcije 30 godina nakon početka imunizacije (8). Jedan od problema su i nevakcinisani medicinski radnici koji su u povećanom riziku za infekciju usled profesionalne izloženosti.…”
Section: Diskusijaunclassified